deca durabolin results

All adverse reactions. below are typical for the preparation of active substances – salmeterol and fluticasone propionate in particular. Adverse drug reaction profile Seretid Multidisk profile does not differ from its undesirable reactions of active substances. Adverse deca durabolin results reactions shown below are listed in accordance with a lesion of organs and organ systems, and frequency of occurrence. Frequency categories were formed pa based on data of clinical trials and post-marketing drug surveillance.

Data from clinical studies

The frequency of occurrence of adverse reactions

Infectious and parasitic diseases
often:. Candidiasis of the mouth and throat, pneumonia
Rare: esophageal candidiasis.

Violations by the immune system
Hypersensitivity reactions
Uncommon: hypersensitivity skin reactions. dyspnoea.
Rare: anaphylactic reactions.

Disorders of the endocrine system
Possible systemic effects (see “Special Instructions” section.)
Uncommon: Cataract.
Rare: glaucoma.

Violations of the metabolism and nutrition
Infrequent: hyperglycemia.
Very rare: hypokalemia.

Mental disorders
Uncommon: anxiety. sleep disturbances.
rare: changes in behavior, including hyperactivity and irritability (especially in children).

Violations by neranoy system Very common: headache (see “Special Instructions” section.).
Uncommon: tremor (see “Special Instructions” section.).

Violations of the heart
Uncommon: palpitations (see “Precautions” and “Cautions”.). tachycardia, atrial fibrillation.
Rare: arrhythmia. including ventricular arrhythmia, supraventricular tachycardia and extrasystoles.

Disorders of the respiratory system, organs, thoracic and mediastinal disorders
Common: hoarseness and / or dysphonia.
Uncommon: throat irritation.

Disorders of the skin and subcutaneous tissue disorders
Uncommon: bruising.

Violations of the musculoskeletal and connective tissue disorders
Common: muscle cramps, arthralgia.

These post-marketing observational

The incidence of adverse reactions occurrence

Violations by the immune system
Hypersensitivity reactions
Rare: angioedema (mainly facial swelling and oropharynx), brophospazm.

Disorders deca durabolin results of the endocrine system
Possible systemic effects (see “Special Instructions”.)
Rare: Cushing’s syndrome, Cushingoid symptoms, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density.

Disorders of the respiratory system, organs, thoracic and mediastinal disorders
Rare: paradoxical bronchospasm (see “Special Instructions” section.).


We do not recommend use of the drug in doses higher than those specified in the section “How to use and dosage.” It is important to regularly review the patient’s dosage regimen and reduce the dose to the lowest of the recommended doses for ensuring effective control of symptoms .

Expected signs and symptoms of salmeterol overdose are typical of excessive  stimulation and include tremor, headache, tachycardia, increased systolic blood pressure and hypokalaemia.Acute overdose of fluticasone propionate when inhaled can cause a temporary suppression of the hypothalamic-pituitary-adrenal system.

This is not usually requires some extra measures because normal adrenal function is restored within a few days.

When receiving the above formulation at a dose recommended for a long period of time, perhaps a significant inhibition of adrenocortical function. Described rare cases of acute adrenal crisis, which occurred mostly in children treated with doses higher than recommended for a long time (months or years). Acute adrenal crisis manifested hypoglycemia accompanied by confusion and / or convulsions. Situations that can serve as a triggering factor of acute adrenal crisis, include trauma, surgery, infection or any rapid reduction of the dose which is part of the drug deca durabolin results fluticasone propionate.

No specific treatment of overdosage of salmeterol and fluticasone propionate. In case of overdose should be supportive therapy and observe the patient’s condition. In chronic overdose recommended control reserve of adrenocortical function.

Interaction with other drugs

Because of the risk of bronchospasm should avoid the use of selective and nonselective beta-blockers, except in cases where they are essential to the patient.